← All verdicts
Verdict

Data Unavailable

Every analyzed stock in Data Unavailable2,921 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
"Data Unavailable" by: Model value (price vs DCF) Owner-earnings return (equity bond)

This lens: price against our probability-weighted DCF value (P/IV). Its own forward record began accruing on 2026-09-10 (daily snapshots); until a year of it exists, the panel below tests the nearest cousin we can measure point-in-time — cheap on book value — and says so.

Market state today: Calm — the S&P 500 closed 3.1% below its 1-year high (as of 2026-09-16). Our rule, the same one used to split every backtest on this site: sell-off = 10% or more below the 1-year high, borderline from 5%, calm otherwise. A further 7.2% fall from here would put us in a sell-off. Since 2006 the market has been in a sell-off 16.6% of the time, across 13 episodes (red bands).
2007200920112013201520172019202120232025
S&P 500 (SPY, adjusted) distance from its trailing 1-year high, weekly. Amber band: borderline (−5% to −10%). Red band: sell-off (below −10%). The dot is today. History to 2026-08-19 from the research database; today from the live feed.
Backtest · point in time · 8,702 entries in the study

Does this screen work? The record for exactly these filters

Screen tested: Proxy: price-to-book ≤ 1.2 (undervalued band has no point-in-time history yet) · bought the day of the annual report, held 12 months
Probable Buy every company that met this screen on the day it filed its annual report, hold 12 months: on average it beat the S&P 500 by +12.6 pts (1,427 entries, 311 companies, very unlikely to be luck). 50% of entries beat the S&P; 25% beat it by 30 points or more; 30% trailed it by 20 points or more. Owning everything instead averaged +1.7 pts, so the screen's edge is +10.9 pts.
+12.6 ptsvs S&P, average
50%beat the S&P
25%up 30+ pts vs S&P
30%down 20+ pts vs S&P
+14.0 ptsvs small caps, 12 mo
−15.1 pts 2019worst year to buy ?
6.1luck check ?
Does the holding period matter?3 mo: +2.3 pts 49% beat6 mo: +4.6 pts 49% beat12 mo: +12.6 pts 50% beat24 mo: +21.8 pts 46% beat3 yr, per yr: +1.3 pts 40% beat
Market state at entryCompany-yearsvs S&P 12 movs small caps
Calm ◀ today1,245+7.9 pts t 4.6+10.1 pts
Sell-off (S&P ≥10% off high)182+44.5 pts t 4.0+40.7 pts
Sector (SEC group)nvs S&P 12 mo3 yrs / yr
Industrials & manufacturing466+13.0 pts t 4.0−2.2 pts
Energy126+7.4 pts t 1.2−7.8 pts
Other115+8.4 pts t 1.8+3.8 pts
Tech hardware & semis113+10.9 pts t 1.6+2.3 pts
Services96+11.9 pts t 2.7+12.2 pts
Retail & consumer87+17.2 pts t 2.1+10.2 pts
Finance & real estate72−1.7 pts t -0.5−2.4 pts
Utilities65+5.6 pts t 0.6−1.2 pts
Construction53+13.2 pts t 1.7−2.4 pts
Biotech & pharma44+47.1 pts t 1.6+10.0 pts
Telecom & media43+14.0 pts t 0.7−6.3 pts
Software & IT services35+39.9 pts t 1.8+1.2 pts

Holds up out of sample? Before 2018: +10.7 pts (n 629, t 6.0). From 2018: +14.0 pts (n 798, t 4.1). Same sign in both halves.

Year2010201120122013201420152016201720182019202020212022202320242025
vs S&P+13 pts+5 pts+14 pts+18 pts−4 pts−4 pts+22 pts+12 pts−3 pts−15 pts+87 pts+8 pts+17 pts−9 pts−7 pts+15 pts
n254310610178841118178991297276108121115

Read the research behind this screen: Price-to-book still sorts, across all sizes → · Test your own combination in the Screen Lab →

Our model values are recomputed daily but were never stored historically, so this band cannot be backtested honestly yet. Daily snapshots began 2026-09-10; a true record accrues from there. Until then the nearest tested cousin is shown — cheap on book value — and labelled as a proxy. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.

SVACW
Spring Valley Acquisition Corp. III
Valuation N/A
Utilities
Price$1.35
Model IV
P/IV
Limited data — see page
SVAQ
Silicon Valley Acquisition Corp.
Valuation N/A
Financial Services
Price$10.07
Model IV
P/IV
Limited data — see page
SVAQU
Silicon Valley Acquisition Corp.
Valuation N/A
Financial Services
Price$10.48
Model IV
P/IV
Limited data — see page
SVAQW
Silicon Valley Acquisition Corp.
Valuation N/A
Financial Services
Price$0.43
Model IV
P/IV
Limited data — see page
SVCC
Stellar V Capital Corp. (Cayman Islands)
Valuation N/A
Financial Services
Price$10.69
Model IV
P/IV
Limited data — see page
SVCCU
Stellar V Capital Corp. (Cayman Islands)
Valuation N/A
Financial Services
Price$10.71
Model IV
P/IV
Limited data — see page
SVCCW
Stellar V Capital Corp. (Cayman Islands)
Valuation N/A
Financial Services
Price$0.26
Model IV
P/IV
Limited data — see page
SVCO
Silvaco Group, Inc.
Valuation N/A
Technology Risk 51 · Elevated
Price$6.71
Model IV
P/IV
Market implies +19.9%/yr vs model +7.8% · above model
SVIV
Spring Valley Acquisition Corp. IV
Valuation N/A
Financial Services
Price$10.18
Model IV
P/IV
Limited data — see page
SVIVU
Spring Valley Acquisition Corp. IV
Valuation N/A
Financial Services
Price$10.56
Model IV
P/IV
Limited data — see page
SVIVW
Spring Valley Acquisition Corp. IV
Valuation N/A
Financial Services
Price$0.75
Model IV
P/IV
Limited data — see page
SVIX
VS Trust
Valuation N/A
Financial Services Risk 51 · Elevated
Price$28.12
Model IV
P/IV
Limited data — see page
SVM
SILVERCORP METALS INC
Valuation N/A
Basic Materials Risk 35 · Moderate
Price$11.91
Model IV
P/IV
Limited data — see page
SVRA
Savara Inc
Valuation N/A
Healthcare Risk 42 · Elevated
Price$5.30
Model IV
P/IV
Limited data — see page
SVRE
SaverOne 2014 Ltd.
Valuation N/A
Technology Risk 33 · Moderate
Price$2.60
Model IV
P/IV
Limited data — see page
SVREW
SaverOne 2014 Ltd.
Valuation N/A
Technology Risk 55 · Elevated
Price$0.01
Model IV
P/IV
Limited data — see page
SVXY
ProShares Trust II
Valuation N/A
Financial Services Risk 54 · Elevated
Price$62.61
Model IV
P/IV
Limited data — see page
SWMR
Swarmer, Inc
Valuation N/A
Technology Risk 49 · Elevated
Price$32.16
Model IV
P/IV
Limited data — see page
SWVL
Swvl Holdings Corp
Valuation N/A
Technology
Price$7.12
Model IV
P/IV
Limited data — see page
SWVLW
Swvl Holdings Corp
Valuation N/A
Technology
Price$0.01
Model IV
P/IV
Limited data — see page
SWZ
Total Return Securities Fund
Valuation N/A
Unknown
Price$5.92
Model IV
P/IV
Limited data — see page
SXI
STANDEX INTERNATIONAL CORP/DE/
Valuation N/A
Industrials Risk 57 · Elevated
Price$257.26
Model IV
P/IV
Market implies +29.3%/yr vs model +5.1% · above model
SYNA
SYNAPTICS Inc
Valuation N/A
Technology Risk 60 · High
Price$101.03
Model IV
P/IV
Market implies +28.7%/yr vs model +2.0% · above model
SYNX
Silynxcom Ltd.
Valuation N/A
Technology Risk 33 · Moderate
Price$0.84
Model IV
P/IV
Limited data — see page
SYRE
Spyre Therapeutics, Inc.
Valuation N/A
Healthcare Risk 31 · Moderate
Price$90.95
Model IV
P/IV
Market implies +150.0%/yr vs model +15.0% · above model
SZZL
Sizzle Acquisition Corp. II
Valuation N/A
Financial Services
Price$10.47
Model IV
P/IV
Limited data — see page
SZZLR
Sizzle Acquisition Corp. II
Valuation N/A
Financial Services
Price$0.17
Model IV
P/IV
Limited data — see page
SZZLU
Sizzle Acquisition Corp. II
Valuation N/A
Financial Services
Price$10.54
Model IV
P/IV
Limited data — see page
TACH
Titan Acquisition Corp.
Valuation N/A
Financial Services
Price$10.50
Model IV
P/IV
Limited data — see page
TACHU
Titan Acquisition Corp.
Valuation N/A
Financial Services
Price$10.75
Model IV
P/IV
Limited data — see page
TACHW
Titan Acquisition Corp.
Valuation N/A
Financial Services
Price$0.58
Model IV
P/IV
Limited data — see page
TACO
Berto Acquisition Corp.
Valuation N/A
Financial Services Risk 29 · Moderate
Price$10.49
Model IV
P/IV
Limited data — see page
TACOU
Berto Acquisition Corp.
Valuation N/A
Financial Services Risk 45 · Elevated
Price$10.86
Model IV
P/IV
Limited data — see page
TACOW
Berto Acquisition Corp.
Valuation N/A
Financial Services Risk 58 · Elevated
Price$0.73
Model IV
P/IV
Limited data — see page
TAGS
Teucrium Commodity Trust
Valuation N/A
Financial Services Risk 36 · Moderate
Price$28.00
Model IV
P/IV
Limited data — see page
TAK
TAKEDA PHARMACEUTICAL CO LTD
Valuation N/A
Healthcare Risk 37 · Moderate
Price$18.26
Model IV
P/IV
Limited data — see page
TANH
TANTECH HOLDINGS LTD
Valuation N/A
Basic Materials Risk 55 · Elevated
Price$20.45
Model IV
P/IV
Market implies -0.8%/yr vs model +0.0% · in line
TAOP
Taoping Inc.
Valuation N/A
Technology Risk 33 · Moderate
Price$0.77
Model IV
P/IV
Market implies -50.0%/yr vs model +12.3% · below model
TAOX
TAO Synergies Inc.
Valuation N/A
Financial Services Risk 42 · Elevated
Price$3.90
Model IV
P/IV
Market implies +94.7%/yr vs model +15.0% · above model
TARA
Protara Therapeutics, Inc.
Valuation N/A
Healthcare Risk 44 · Elevated
Price$3.82
Model IV
P/IV
Limited data — see page
TAVI
Tavia Acquisition Corp.
Valuation N/A
Financial Services Risk 30 · Moderate
Price$10.74
Model IV
P/IV
Limited data — see page
TAVIR
Tavia Acquisition Corp.
Valuation N/A
Financial Services Risk 43 · Elevated
Price$0.11
Model IV
P/IV
Limited data — see page
TAVIU
Tavia Acquisition Corp.
Valuation N/A
Financial Services Risk 42 · Elevated
Price$10.85
Model IV
P/IV
Limited data — see page
TBBB
BBB FOODS INC
Valuation N/A
Consumer Defensive
Price$51.45
Model IV
P/IV
Limited data — see page
TBH
Brag House Holdings, Inc.
Valuation N/A
Financial Services Risk 35 · Moderate
Price$3.53
Model IV
P/IV
Market implies +150.0%/yr vs model +15.0% · above model
TBLD
Thornburg Income Builder Opportunities Trust
Valuation N/A
Unknown
Price$21.13
Model IV
P/IV
Limited data — see page
TBN
Tamboran Resources Corp
Valuation N/A
Energy Risk 42 · Elevated
Price$39.13
Model IV
P/IV
Market implies +80.1%/yr vs model +4.0% · above model
TC
Token Cat Ltd
Valuation N/A
Technology Risk 42 · Elevated
Price$1.95
Model IV
P/IV
Market implies +99.2%/yr vs model +2.0% · above model
TCGL
TechCreate Group Ltd.
Valuation N/A
Technology Risk 32 · Moderate
Price$172.84
Model IV
P/IV
Market implies +65.6%/yr vs model +15.0% · above model
TCRT
Alaunos Therapeutics, Inc.
Valuation N/A
Healthcare Risk 34 · Moderate
Price$1.51
Model IV
P/IV
Market implies +92.7%/yr vs model +2.0% · above model
TCRX
TScan Therapeutics, Inc.
Valuation N/A
Healthcare Risk 30 · Moderate
Price$0.32
Model IV
P/IV
Market implies +60.9%/yr vs model +2.0% · above model
TD
TORONTO DOMINION BANK
Valuation N/A
Financial Services Risk 41 · Elevated
Price$121.47
Model IV
P/IV
Limited data — see page
TDAC
Translational Development Acquisition Corp.
Valuation N/A
Financial Services
Price$10.86
Model IV
P/IV
Limited data — see page
TDACU
Translational Development Acquisition Corp.
Valuation N/A
Financial Services
Price$12.57
Model IV
P/IV
Limited data — see page
TDACW
Translational Development Acquisition Corp.
Valuation N/A
Financial Services
Price$1.45
Model IV
P/IV
Limited data — see page
TDF
TEMPLETON DRAGON FUND INC
Valuation N/A
Unknown
Price$10.39
Model IV
P/IV
Limited data — see page
TDIC
Dreamland Ltd
Valuation N/A
Industrials Risk 32 · Moderate
Price$2.08
Model IV
P/IV
Limited data — see page
TDOG
21Shares Dogecoin ETF
Valuation N/A
Financial Services Risk 51 · Elevated
Price$16.98
Model IV
P/IV
Limited data — see page
TDTH
Trident Digital Tech Holdings Ltd
Valuation N/A
Technology Risk 36 · Moderate
Price$1.68
Model IV
P/IV
Market implies +150.0%/yr vs model +2.0% · above model
TDUP
ThredUp Inc.
Valuation N/A
Consumer Cyclical Risk 41 · Elevated
Price$2.61
Model IV
P/IV
Market implies +20.8%/yr vs model +5.4% · above model